A pivotal trial for Captisol-enabled Iohexol (CE-Iohexol)
Latest Information Update: 22 Oct 2020
At a glance
- Drugs Iohexol (Primary)
- Indications Cardiovascular disorders
- Focus Diagnostic use; Registrational
- Sponsors Ligand Pharmaceuticals
- 20 Oct 2020 According to a Ligand Pharmaceuticals media release, favorable results from this study will lead to a 505(b)(2) regulatory filing.
- 23 Sep 2020 According to a Ligand Pharmaceuticals media release, the company expects to initiate this trial by December 2020 and results are expected within two years.
- 07 Aug 2020 New trial record